Integrated Research Limited (IRI) AI Stock Analysis

• Market Cap: AU$83.36M
• Dividend Yield: 4.26%
• Average Volume (3M): 141.43K
• Price to Earnings (P/E): 4.0
• Beta (1Y): 0.88
• Revenue Growth: -1.32%
• EPS Growth: N/A
• Country: AU
• Employees: 142
• Sector: Technology
• Sector Strength: 91
• Industry: Software - Application
• EPS (TTM): 0.03
• Shares Outstanding: 177,352,700
• 10 Day Avg. Volume: 116,578
• 30 Day Avg. Volume: 141,430
• PEG Ratio: 1.45
• Price to Book (P/B): 8.24
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 28.83
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$0.50
• Price Target Upside: 6.74% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 71 Outperform
• Price Target: AU$0.50 ▲(6.38%Upside)

Integrated Research Limited's strong financial recovery and attractive valuation are significant strengths. However, mixed technical indicators suggest caution. Sustaining cash flow growth remains a key focus to maintain operational momentum.

Integrated Research Limited Business Overview & Revenue Model

Company Description

Integrated Research Limited designs, develops, implements, and sells systems and applications management computer software for business-critical computing, and unified communication and payment networks. The company offers Prognosis, an integrated suite of monitoring and management software designed to give an organization's management and technical personnel operational insight into the HP NonStop platform, distributed system servers, unified communications, payment environments, and the business applications. It also provides testing, maintenance, and professional services, as well as software as a service solution. The company offers its products in approximately 60 countries through direct sales offices in the United States, the United Kingdom, Germany, Singapore, and Australia, as well as through channel-driven distribution networks internationally. It serves stock exchanges, banks, credit card companies, telecommunications carriers, service providers, and manufacturers. The company was incorporated in 1988 and is based in North Sydney, Australia.

How the Company Makes Money

Integrated Research Limited generates revenue primarily through the sale of its Prognosis software solutions, which are offered via perpetual licenses, subscription models, and cloud-based services. The company also earns money from maintenance and support services provided to its clients. Key revenue streams include licensing fees, subscription fees, and service contracts. IRI's business model is supported by strategic partnerships with major IT and communications firms, which help expand its market reach and enhance its product offerings. Additionally, the company invests in research and development to continuously innovate and maintain its competitive edge in the performance management industry.

Integrated Research Limited Financial Statement Overview

Summary

Integrated Research Limited has demonstrated significant financial improvement with strong revenue growth and profitability. The company shows efficient use of equity and robust cash flow generation, although attention is required to sustain cash flow growth.

Income Statement

Integrated Research Limited has shown strong recovery with a notable revenue growth of 19.3% this year. The company has achieved a gross profit margin of 100%, and a remarkable improvement in net profit margin from -41.8% to 32.6%. EBIT and EBITDA margins have also turned positive, indicating enhanced operational efficiency.

Balance Sheet

The balance sheet reflects a solid equity position with an equity ratio of 77.4%. The debt-to-equity ratio is low at 0.02, indicating minimal leverage. Return on Equity (ROE) improved significantly to 30.7%, reflecting effective use of equity to generate profits.

Cash Flow

Operating cash flow remains strong, although slightly down from the previous year. The free cash flow has almost doubled, leading to a free cash flow to net income ratio of 0.56, showcasing solid cash generation capabilities. However, the operating cash flow to net income ratio decreased to 0.56.

Breakdown	TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	71.29M	83.29M	69.83M	62.87M	78.49M	110.91M
Gross Profit	34.05M	83.29M	28.94M	21.73M	35.12M	56.35M
EBITDA	14.11M	25.34M	-1.07M	10.40M	23.21M	43.91M
Net Income	20.52M	27.13M	-29.23M	1.54M	7.93M	24.05M
Balance Sheet
Total Assets	118.16M	114.19M	90.84M	132.20M	136.63M	141.23M
Cash, Cash Equivalents and Short-Term Investments	32.59M	31.89M	18.55M	12.33M	12.15M	9.74M
Total Debt	2.20M	1.72M	3.05M	4.87M	13.08M	11.51M
Total Liabilities	26.31M	25.82M	30.97M	45.08M	53.29M	58.70M
Stockholders Equity	91.85M	88.36M	59.87M	87.11M	83.34M	82.52M
Cash Flow
Free Cash Flow	9.87M	15.22M	8.20M	6.97M	9.67M	9.55M
Operating Cash Flow	10.11M	15.27M	15.99M	18.76M	21.91M	24.76M
Investing Cash Flow	2.79M	2.27M	-8.90M	-11.80M	-12.24M	-15.20M
Financing Cash Flow	-5.26M	-1.69M	-1.63M	-6.96M	-6.44M	-9.33M

Integrated Research Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.47
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:IRI, the sentiment is Positive. The current price of 0.47 is above the 20-day moving average (MA) of 0.42, above the 50-day MA of 0.44, and below the 200-day MA of 0.48, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 65.54 is Neutral, neither overbought nor oversold. The STOCH value of 80.26 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:IRI.

Integrated Research Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IRI	71 Outperform	AU$83.36M	4.01	25.65%	4.26%	-1.32%	―
AMX	55 Neutral	AU$22.80M	―	-24.21%	―	-11.35%	-49.13%
PRO	51 Neutral	AU$30.97M	―	-52.29%	―	4.10%	-115.05%
Sector *	50 Neutral	AU$1.49B	2.06	-31.50%	3.11%	16.21%	-7.40%
FLX	43 Neutral	AU$44.16M	―	-1801.55%	―	27.94%	28.75%
NVU	35 Underperform	AU$52.07M	―	-243.28%	―	-32.45%	33.72%

Integrated Research Limited Corporate Events

Integrated Research Limited Announces Cessation of Securities

Integrated Research Limited announced the cessation of certain securities, specifically 1,012,530 performance rights and 655,809 options, due to the conditions for these securities not being met or becoming incapable of being satisfied. This cessation may impact the company’s capital structure and could influence stakeholder perceptions regarding the company’s operational and financial strategies.